175 related articles for article (PubMed ID: 12034366)
1. Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases.
Nishiyama T; Ogura K; Nakano H; Ohnuma T; Kaku T; Hiratsuka A; Muro K; Watabe T
Biochem Pharmacol; 2002 May; 63(10):1817-30. PubMed ID: 12034366
[TBL] [Abstract][Full Text] [Related]
2. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.
Sun D; Sharma AK; Dellinger RW; Blevins-Primeau AS; Balliet RM; Chen G; Boyiri T; Amin S; Lazarus P
Drug Metab Dispos; 2007 Nov; 35(11):2006-14. PubMed ID: 17664247
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.
Sun D; Chen G; Dellinger RW; Duncan K; Fang JL; Lazarus P
Breast Cancer Res; 2006; 8(4):R50. PubMed ID: 16884532
[TBL] [Abstract][Full Text] [Related]
5. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes.
Vaidyanathan JB; Walle T
Drug Metab Dispos; 2002 Aug; 30(8):897-903. PubMed ID: 12124307
[TBL] [Abstract][Full Text] [Related]
7. Phase II metabolism of betulin by rat and human UDP-glucuronosyltransferases and sulfotransferases.
Hu Z; Wang Z; Luo S; James MO; Wang Y
Chem Biol Interact; 2019 Apr; 302():190-195. PubMed ID: 30776358
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.
Blevins-Primeau AS; Sun D; Chen G; Sharma AK; Gallagher CJ; Amin S; Lazarus P
Cancer Res; 2009 Mar; 69(5):1892-900. PubMed ID: 19244109
[TBL] [Abstract][Full Text] [Related]
9. A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives.
Greer AK; Dates CR; Starlard-Davenport A; Edavana VK; Bratton SM; Dhakal IB; Finel M; Kadlubar SA; Radominska-Pandya A
Drug Metab Dispos; 2014 Sep; 42(9):1392-400. PubMed ID: 24917585
[TBL] [Abstract][Full Text] [Related]
10. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
Boocock DJ; Maggs JL; Brown K; White IN; Park BK
Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
[TBL] [Abstract][Full Text] [Related]
11. Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.
Falany JL; Pilloff DE; Leyh TS; Falany CN
Drug Metab Dispos; 2006 Mar; 34(3):361-8. PubMed ID: 16381672
[TBL] [Abstract][Full Text] [Related]
12. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human.
Aumont V; Krisa S; Battaglia E; Netter P; Richard T; Mérillon JM; Magdalou J; Sabolovic N
Arch Biochem Biophys; 2001 Sep; 393(2):281-9. PubMed ID: 11556815
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.
Zhou J; Tracy TS; Remmel RP
Drug Metab Dispos; 2010 Mar; 38(3):431-40. PubMed ID: 20007295
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxytamoxifen sulfation metabolism.
Chen G; Yin S; Maiti S; Shao X
J Biochem Mol Toxicol; 2002; 16(6):279-85. PubMed ID: 12481303
[TBL] [Abstract][Full Text] [Related]
15. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
[TBL] [Abstract][Full Text] [Related]
16. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO
Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.
Kuuranne T; Kurkela M; Thevis M; Schänzer W; Finel M; Kostiainen R
Drug Metab Dispos; 2003 Sep; 31(9):1117-24. PubMed ID: 12920167
[TBL] [Abstract][Full Text] [Related]
18. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
[TBL] [Abstract][Full Text] [Related]
19. Triclosan as a substrate and inhibitor of 3'-phosphoadenosine 5'-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions.
Wang LQ; Falany CN; James MO
Drug Metab Dispos; 2004 Oct; 32(10):1162-9. PubMed ID: 15269185
[TBL] [Abstract][Full Text] [Related]
20. Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.
Shibutani S; Shaw PM; Suzuki N; Dasaradhi L; Duffel MW; Terashima I
Carcinogenesis; 1998 Nov; 19(11):2007-11. PubMed ID: 9855017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
